Ortivus AB Series A | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK0.47 |
Market Cap |
SEK176.69 M |
Shares Outstanding |
1.66 M |
Public Float |
- |
Ortivus AB Series B | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK0.47 |
Market Cap |
SEK89.44 M |
Shares Outstanding |
34.84 M |
Public Float |
- |
Address |
Karlsrovägen 2D Danderyd AB 182 17 Sweden |
Employees | - |
Website | http://www.ortivus.com |
Updated | 07/08/2019 |
Ortivus AB engages in the development and sale of clinical devices and systems. The firm offers electronic patient record, summary care record, and personal demographics service. It also includes consulting, support, implementation and training services. |